Abstract
The importance of P-glycoprotein (P-gp) in AML has been well documented. Resistance to the anthracyclines can be overcome by several agents including Cyclosporin A (CsA), PSC833 and GF120918. We describe an investigation into the expression, using MRK16 and UIC2, and function of P-gp using daunorubicin with and without modulators by flow cytometric analysis on previously frozen blast cells from 27 patients with primary or secondary AML. We compared this with the in vitro chemosensitivity, using the MTT assay, of fresh blast cells from the same patients. Whilst we found a correlation between P-gp function using CsA and GF120918 and expression using MRK16 (p<0.05) and (p<0.02) respectively, we were unable to find any overall correlation between expression and function of P-gp with either in vitro sensitivity to the anthracyclines, previous treatment, or 1° or 2° disease. However it was possible to identify individual patients whose cells exhibited P-gp expression and function teamed with in vitro resistance to, and modification of, the anthracyclines. Furthermore, it is possible to identify which modulator had the greatest effect. The fact that we obtained higher indications of resistance reversal using the MTT assay along with finding P-gp expression and function in patients sensitive to the anthracyclines, suggests studies of P-gp should be teemed with chemosensitivity testing to identify specific patients who will benefit.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Tsuruo T. Mechanisms of multidrug resistance and implications for therapy. Japanese Journal of Cancer Research, (1988) 79, 285–296.
Campos L. Guyotat D. Archimbaud E. et al. Clinical significance of multidrug resistance P-Glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood (1992) 79, 473–476.
List A. Spier C. Cline A. et al. Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br J Haematology (1991) 78, 28–34.
Xu-Rong Jiang. Stephen M Kelsey. Yu-Ling Wu. Adrian C Newland. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC833. Br J Haematology, (1995) 90, 375–383.
Hyafil F. Vergely C. Du Vignaud P. Grand-Perret T. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Research, (1993) 53, 4595–4602.
Ivy SP. Olshefski RS. Taylor BJ. Patel KM. Reaman GH. Correlation of P-glycoprotein expression and function in childhood acute leukemia: A children’s cancer group study. Blood, (1996) 88. 309–318.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Elgie, A.W., Sargent, J.M., Williamson, C.J., Lewandowicz, G.M., Taylor, C.G. (1999). Comparison of P-Glycoprotein Expression and Function with in vitro Sensitivity to Anthracyclines in AML. In: Kaspers, G.J.L., Pieters, R., Veerman, A.J.P. (eds) Drug Resistance in Leukemia and Lymphoma III. Advances in Experimental Medicine and Biology, vol 457. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4811-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4811-9_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7180-9
Online ISBN: 978-1-4615-4811-9
eBook Packages: Springer Book Archive